PropThink: Lightweight Contender ACHN Declines on Gilead’s Latest Hepatitis Data

[ACN Newswire] – By Jake KingWith Gilead’s (NASDAQ:GILD) reported 100% Hepatitis C virologic response rate over the weekend, rivals Achillion (NASDAQ:ACHN) and Vertex (NASDAQ:VRTX) traded down 15% and 5% respectively at … more

View todays social media effects on VRTX

View the latest stocks trending across Twitter. Click to view dashboard